Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 8, 2026, the Compensation Committee (the "Committee") of the Board of Directors of STAAR Surgical Company (the "Company") approved an increase to the annual base salary of Deborah Andrews, the Company's Interim Co-Chief Executive Officer and Chief Financial Officer from $512,000 to $575,000. In addition, the Committee approved an increase in the target annual cash bonus for Ms. Andrews from 55% to 60% of her base salary. Both the base salary increase and bonus increase are effective June 8, 2026.

The compensation adjustments were made following the Committee's review of competitive market compensation data and in recognition of Ms. Andrew's contributions to the Company's strategic and operational objectives.